Heterozygous disruption of SERCA2a is not associated with impairment of cardiac performance in humans: implications for SERCA2a as a therapeutic target in heart failure
about
The human subject: an integrative animal model for 21(st) century heart failure researchAcrokeratosis verruciformis of hopf associated with dilated cardiomyopathyMice carrying a conditional Serca2(flox) allele for the generation of Ca(2+) handling-deficient mouse models.Prominent heart organ-level performance deficits in a genetic model of targeted severe and progressive SERCA2 deficiency.SERCA2 Haploinsufficiency in a Mouse Model of Darier Disease Causes a Selective Predisposition to Heart FailureDisorders of Keratinization
P2860
Heterozygous disruption of SERCA2a is not associated with impairment of cardiac performance in humans: implications for SERCA2a as a therapeutic target in heart failure
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Heterozygous disruption of SER ...... peutic target in heart failure
@ast
Heterozygous disruption of SER ...... peutic target in heart failure
@en
type
label
Heterozygous disruption of SER ...... peutic target in heart failure
@ast
Heterozygous disruption of SER ...... peutic target in heart failure
@en
prefLabel
Heterozygous disruption of SER ...... peutic target in heart failure
@ast
Heterozygous disruption of SER ...... peutic target in heart failure
@en
P2093
P2860
P50
P356
P1433
P1476
Heterozygous disruption of SER ...... peutic target in heart failure
@en
P2093
P2860
P304
P356
10.1136/HRT.2004.051037
P407
P577
2005-04-21T00:00:00Z